Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study
Open Access
- 1 March 2014
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 14 (3) , 220-226
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (098051)
- Developmental Award from the American Sexually Transmitted Diseases Association and National Institutes of Health (1-K08-AI104767-01)
- National Institutes of Health (5-K01-AI101010-02)
- National Institute of General Medical Sciences (U54GM088558)
This publication has 36 references indexed in Scilit:
- An epidemiological view of microbial genomic dataThe Lancet Infectious Diseases, 2013
- Investigation of disease outbreaks with genome sequencingThe Lancet Infectious Diseases, 2013
- Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, CanadaJAMA, 2013
- Gonococcal Resistance: Are Cephalosporins Next?Current Infectious Disease Reports, 2011
- Evolution of MRSA During Hospital Transmission and Intercontinental SpreadScience, 2010
- Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxoneJournal of Antimicrobial Chemotherapy, 2010
- Mosaic Penicillin-Binding Protein 2 in Neisseria gonorrhoeae Isolates Collected in 2008 in San Francisco, CaliforniaAntimicrobial Agents and Chemotherapy, 2009
- Velvet: Algorithms for de novo short read assembly using de Bruijn graphsGenome Research, 2008
- RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed modelsBioinformatics, 2006
- Epidemiology and Treatment of Penicillinase-producing Neisserla gonorrhoeaeSexually Transmitted Diseases, 1979